🇺🇸 FDA
Patent

US 11400116

Systems and methods for targeting cancer cells

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 11400116 (Systems and methods for targeting cancer cells) held by The Regents of the University of California expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/47, A61K38/177